ARL4A
ADP-ribosylation factor-like protein 4A
Also known as: ARL4, ARL4A_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P40617
- Gene
- ARL4A
- Ensembl
- ENSG00000122644
- Chromosome
- 7
- Canonical length
- 200 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Cytosol
OverviewNCBI Gene
ADP-ribosylation factor-like 4A is a member of the ADP-ribosylation factor family of GTP-binding proteins. ARL4A is similar to ARL4C and ARL4D and each has a nuclear localization signal and an unusually high guaninine nucleotide exchange rate. ARL4A is located in both the nuclear and extranuclear cell compartments. Multiple transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
200 residues, UniProt reviewed canonical sequence.
>P40617|ARL4A
1 MGNGLSDQTS ILSNLPSFQS FHIVILGLDC AGKTTVLYRL QFNEFVNTVP TKGFNTEKIK
61 VTLGNSKTVT FHFWDVGGQE KLRPLWKSYT RCTDGIVFVV DSVDVERMEE AKTELHKITR
121 ISENQGVPVL IVANKQDLRN SLSLSEIEKL LAMGELSSST PWHLQPTCAI IGDGLKEGLE
181 KLHDMIIKRR KMLRQQKKKRLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ARL4A can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.3
- Highest tissue expression
- 181 nTPM
Expression across tissuesHPA
Tissue
- testis: 181 nTPM
- bone marrow: 93 nTPM
- skin: 85 nTPM
- salivary gland: 82 nTPM
- vagina: 63 nTPM
- small intestine: 59 nTPM
Single-cell type
- late spermatids: 6,442 nCPM
- late primary spermatocytes: 1,592 nCPM
- early spermatids: 1,325 nCPM
- breast lactating cells: 1,048 nCPM
- enterocytes: 541 nCPM
- syncytiotrophoblasts: 490 nCPM
Immune cell
- naive B-cell: 45 nTPM
- memory B-cell: 41 nTPM
- non-classical monocyte: 32 nTPM
- MAIT T-cell: 32 nTPM
- memory CD4 T-cell: 27 nTPM
- intermediate monocyte: 26 nTPM
Brain region
- cerebral cortex: 34 nTPM
- choroid plexus: 30 nTPM
- basal ganglia: 24 nTPM
- white matter: 21 nTPM
- amygdala: 18 nTPM
- hippocampal formation: 15 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.55
- gnomAD pLI
- 0.81
- gnomAD missense Z
- 0.46
- DepMap mean gene effect
- -0.06
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 8% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ARL4A in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ARL4A as an antibody target. Whether an autoantibody or antibody against ARL4A could matter depends on whether native ARL4A is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ARL4A is annotated at the cell surface, where native ARL4A is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label ARL4A as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...